Mizuho Boosts Acadia Healthcare (NASDAQ:ACHC) Price Target to $78.00

Acadia Healthcare (NASDAQ:ACHCGet Rating) had its target price raised by Mizuho from $69.00 to $78.00 in a research report released on Friday morning, The Fly reports. The brokerage currently has a maintains rating on the stock.

Several other research firms have also issued reports on ACHC. BMO Capital Markets increased their target price on Acadia Healthcare from $67.00 to $82.00 in a report on Friday, May 6th. UBS Group upped their price objective on Acadia Healthcare from $82.00 to $90.00 and gave the stock a buy rating in a research report on Thursday. StockNews.com started coverage on Acadia Healthcare in a research report on Thursday, March 31st. They set a hold rating for the company. Barclays upped their price objective on Acadia Healthcare from $75.00 to $85.00 and gave the stock a maintains rating in a research report on Friday. Finally, SVB Leerink upped their price objective on Acadia Healthcare from $80.00 to $90.00 and gave the stock an outperform rating in a research report on Friday, April 8th. Three research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of Moderate Buy and a consensus price target of $81.45.

Acadia Healthcare Stock Performance

ACHC opened at $82.91 on Friday. The firm has a market cap of $7.51 billion, a P/E ratio of 31.17, a price-to-earnings-growth ratio of 2.05 and a beta of 1.25. Acadia Healthcare has a 52-week low of $50.07 and a 52-week high of $83.63. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.29 and a current ratio of 1.29. The business’s fifty day moving average is $71.77 and its 200-day moving average is $66.01.

Acadia Healthcare (NASDAQ:ACHCGet Rating) last released its earnings results on Wednesday, July 27th. The company reported $0.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.78 by $0.06. The company had revenue of $651.72 million for the quarter, compared to analyst estimates of $650.80 million. Acadia Healthcare had a return on equity of 10.16% and a net margin of 10.16%. Acadia Healthcare’s quarterly revenue was up 11.9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.71 EPS. Sell-side analysts expect that Acadia Healthcare will post 3.09 EPS for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

Several large investors have recently bought and sold shares of the company. CWM LLC acquired a new stake in shares of Acadia Healthcare in the fourth quarter valued at about $33,000. Point72 Hong Kong Ltd acquired a new stake in Acadia Healthcare during the first quarter worth approximately $38,000. Quent Capital LLC acquired a new stake in Acadia Healthcare during the fourth quarter worth approximately $115,000. Tranquility Partners LLC acquired a new stake in Acadia Healthcare during the first quarter worth approximately $209,000. Finally, Walleye Capital LLC acquired a new stake in Acadia Healthcare during the first quarter worth approximately $216,000. 99.66% of the stock is currently owned by institutional investors.

About Acadia Healthcare

(Get Rating)

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico.

See Also

The Fly logo

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Want More Great Investing Ideas?

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.